Two Former Pharma Execs First To Be Charged In Generic Price-Fixing Probe

| |

Two former Heritage Pharmaceuticals executives were accused by federal authorities on Wednesday of conspiring with rivals to fix prices for a widely used antibiotic, the first criminal charges to stem from a two-year investigation into price collusion among generic drug makers. Jeffrey Glazer, who was the chief executive officer, and Jason Malek, the former president, allegedly…